Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel E Behrman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|July 3, 2010
FDA regulations for drug developmentRachel E Behrman, Janet Woodcock
Future Medicinal Chemistry|March 24, 2011
Challenges, successes and hopes in the development of novel TB therapeuticsLeonard V Sacks, Rachel E Behrman
Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspectiveLeonard V Sacks, Rachel E Behrman
The New England Journal of Medicine|February 18, 2011
Development of novel combination therapiesJanet Woodcock, Joseph P Griffin, Rachel E Behrman
Annual Review of Medicine|September 3, 2010
Role of postmarketing surveillance in contemporary medicineJanet Woodcock, Rachel E Behrman, Gerald J Dal Pan
The New England Journal of Medicine|January 14, 2011
Developing the Sentinel System--a national resource for evidence developmentRachel E Behrman, Joshua S Benner, Jeffrey S Brown, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|July 3, 2010
FDA regulations for drug developmentRachel E Behrman, Janet Woodcock
Future Medicinal Chemistry|March 24, 2011
Challenges, successes and hopes in the development of novel TB therapeuticsLeonard V Sacks, Rachel E Behrman
Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspectiveLeonard V Sacks, Rachel E Behrman
The New England Journal of Medicine|February 18, 2011
Development of novel combination therapiesJanet Woodcock, Joseph P Griffin, Rachel E Behrman
Annual Review of Medicine|September 3, 2010
Role of postmarketing surveillance in contemporary medicineJanet Woodcock, Rachel E Behrman, Gerald J Dal Pan
The New England Journal of Medicine|January 14, 2011
Developing the Sentinel System--a national resource for evidence developmentRachel E Behrman, Joshua S Benner, Jeffrey S Brown, et al.
Pageof 1